Abstract 102P
Background
Current pediatric acute myeloid leukemia (pAML) risk stratification heavily relies on cytogenetic findings. However, despite the generally low-risk feature associated with the RUNX1-RUNX1T1 fusion gene, a substantial proportion of patients still experience unfavorable overall survival (OS) and/or event-free survival (EFS). Hence, a specific clinical decision support tool is crucial for the precise evaluation of survival in RUNX1-RUNX1T1+ pAML patients, aiming for enhanced outcomes.
Methods
The study included 2009 pAML patients, of whom 284 carried the RUNX1-RUNX1T1 fusion gene (RR-pAML). The patient data was randomly divided into training and validation subsets; the primary endpoints were OS and EFS. The prognostic model was constructed using univariate and multivariate Cox analyses. Model performance was evaluated using C-index and AUC values.
Results
The RR-pAML model was constructed based on two clinical factors. This model effectively categorized patients into low- and high-risk groups, which exhibited distinct clinical characteristics, response rates, relapse risk and mortality. The 5-year OS rates for the low- and high-risk groups were 91.0% and 73.0%, respectively (p=0.024, AUC 0.69). For EFS, the 5-year rates were 76.8% and 50.2%, respectively (p<0.001, AUC 0.70). Compared to previous prognostic models, the new model demonstrated superior performance in C-index and AUCs. It reclassified 31.7% of patients into the high-risk category and predicted relapse risk.
Conclusions
The new model is a straightforward yet effective clinical stratification tool for pAML patients carrying the RUNX1-RUNX1T1 fusion gene; it enhances risk assessment and facilitates more informed decision-making in the management of RUNX1-RUNX1T1+ patients.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
132P - Deciphering aggressive behavior in uterine inflammatory myofibroblastic tumors: Clinicopathological and molecular analysis
Presenter: Nikola Hajkova
Session: Cocktail & Poster Display session
Resources:
Abstract
133P - Exploring genomic instability at the single-cell level using a new method for the inference of copy number alterations
Presenter: Lucrezia Patruno
Session: Cocktail & Poster Display session
Resources:
Abstract
134P - SPICE: Probabilistic reconstruction of copy-number evolution in cancer
Presenter: Abigail Bunkum
Session: Cocktail & Poster Display session
Resources:
Abstract
135P - Revealing the third kind of pathway of colorectal cancer developing from laterally spreading tumors
Presenter: Jianshe Yang
Session: Cocktail & Poster Display session
Resources:
Abstract
136P - Investigating the evolutionary and regulatory dynamics of acquired resistance to BTK inhibitors in activated B-cell diffuse large B-cell lymphoma cells
Presenter: Luminita Ruje
Session: Cocktail & Poster Display session
Resources:
Abstract
137P - PHANTOM: Bootstrap inference of single-cell tumour phylogenies by integrating sequencing read counts
Presenter: Rija Zaidi
Session: Cocktail & Poster Display session
Resources:
Abstract
138P - Analysis of master regulatory transcription factors and their associated transcriptomic profiles in SCLC patients
Presenter: Janik Riese
Session: Cocktail & Poster Display session
Resources:
Abstract
139P - Rewiring of cis-regulatory and kinase signalling networks in acalabrutinib-resistant ABC DLBCL cells
Presenter: Pavel Artemov
Session: Cocktail & Poster Display session
Resources:
Abstract
140P - MYC subgroups delineate specific transcriptomic landscape and shape response to radiotherapy in SCLC
Presenter: Caterina de Rosa
Session: Cocktail & Poster Display session
Resources:
Abstract
141P - An unconditionally dynamic culture system for cancer stem cell
Presenter: Ya-Juan Zhu
Session: Cocktail & Poster Display session
Resources:
Abstract